(Reuters) - Pfizer Inc on Monday said it plans to internally separate its commercial operations into three business segments, including two units that sell patent-protected branded drugs and one that ...

TRENTON, N.J.-The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales ...

Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from generic versions of its new COVID-19 pill. The agreement covers 95 nations, but it omits some hard-hit ...

The US Food and Drug Administration (FDA) on Friday approved the first generic versions of Pfizer’s blockbuster pain drug Lyrica (pregabalin). The approvals were granted to Alembic Pharmaceuticals, ...

Pfizer’s recent positive data for atirmociclib, tilrekimig, Padcev, and the Lyme disease vaccine candidate highlight pipeline ...

Pfizer Inc. has recently seen how sales of its biggest-selling drug, anti-cholesterol medication Lipitor, started falling when it had to compete with cheaper generic versions. The pharmaceutical giant ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

BridgeBioBBIO stock popped Tuesday on a notable shake-up in the patent battle surrounding Pfizer'sPFE rival drug, tafamidis. A judge ruled that Pfizer will be allowed to present expert testimony ...

Recently, President Trump signed a “most-favored nation” executive order on drug prices with a claim that it would force pharmaceutical companies to lower U.S. prescription costs to match those abroad ...